GEMINI THERAPEUTICS INC (GMTX)       1.64  0 (0%)

1.64  0 (0%)

US36870G1058 - Common Stock

Buy % Consensus

46
Analysts have set a mean price target of 1.79. This target is 8.84% above the current price.
GMTX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about GMTX.
In the previous month the buy percentage consensus was at a similar level.
GMTX was analyzed by 7 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 1.641.521.791.792.10 - -7.62% 8.84% 8.84% 28.05%

Up and Down Grades

Date Firm Action Rating
2022-03-11 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-03-03 SVB Leerink Downgrade Outperform -> Market Perform
2022-03-01 Jefferies Downgrade Buy -> Hold
2022-01-24 SVB Leerink Maintains Outperform
2021-12-20 SVB Leerink Maintains Outperform
2021-12-15 HC Wainwright & Co. Initiate Buy
2021-10-06 Goldman Sachs Maintains Buy
2021-04-08 SVB Leerink Initiate Outperform
2021-03-03 Jefferies Initiate Buy
2021-03-02 Goldman Sachs Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA